Delivery Order SPE2DB22D1017-SPE2DB25FG4FZ
- Not listed
- The Defense Logistics Agency awarded a $2,832.16 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Entecavir 0.5 mg tablets in a 30-count package. This is a firm fixed-price, non-set-aside contract with a completion date of July 22, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $2,275.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count) with an ultimate completion date of June 3, 2025. This non-set-aside, competitively awarded contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order will be performed at the...
- The Defense Logistics Agency awarded a $1,996.61 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Entecavir 0.5 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, consistent with AmerisourceBergen's typical federal procurement profile....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Entecavir 0.5 mg tablets (30-count packaging) with a ceiling value of $1,650.08 under a firm fixed price contract type. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $1,142.56. The order was competitively awarded without set-aside restrictions and is scheduled for completion by August 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a $1,396.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Entecavir 0.5 mg tablets (30-count) with a completion date of June 5, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Entecavir 0.5 mg tablets (30-count) valued at $3,383.40 under a firm fixed-price contract. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Entecavir 0.5 mg tablets in a 30-count configuration. This is a firm fixed price delivery order with a ceiling value of $2,640.56 and an ultimate completion date of September 24, 2025. The award is not set-aside and represents a competitive award to AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania. The contract will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Entecavir 0.5 mg tablets (30-count units) with a ceiling value of $3,232.48 and a firm fixed price. This is a non-set-aside competitive award with an ultimate completion date of June 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Entecavir 0.5 mg tablets in a quantity of 30 units. This firm fixed price delivery order, valued at $2,881.89, was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The contract leverages AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG4FZDelivery Order
The Defense Logistics Agency awarded a $2,516.79 delivery order to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by June 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceuticals and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The smaller delivery order reflects AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement needs through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 6/4/25 |